Thymoma is a rare epithelial tumor originating from the thymus ... However, there is currently a lack of specific molecular pathological markers for the classification of thymomas, which hinders the ...
CBX-12 is under clinical development by Cybrexa and currently in Phase II for Thymoma (Thymic Epithelial Tumor). According to GlobalData, Phase II drugs for Thymoma (Thymic Epithelial Tumor) does not ...
The publisher has been closely monitoring the various markets in Saudi Arabia. This report provides a comprehensive analysis, detailing market size, forecast, trends, growth drivers, and challenges.
A thymoma is a tumor or growth in the thymus gland. Approximately 30%-65% of individuals with thymomas also have MG. With this illness, the immune system creates antibodies that block chemical ...
Cancer is an umbrella term used to characterize the abnormal growth of cells in different organs and tissues. Specific cancer ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
In the last few years, much attention has been paid to this novel tumor marker that can be determined in EDTA-plasma and in the feces. It has been used in diagnosis and surveillance of a variety ...
HMWK Ready to use 34 βE12 Novocastra, New Castle, UK EMA Ready to use GP1.4 Novocastra, New Castle, UK CK Ready to use AE1/AE3 Novocastra, New Castle, UK CK20 Ready to use PW31 Novocastra, New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback